Skip to main content

News Releases

Learn about the Physicians Committee’s latest campaigns. Journalists: For more information or to arrange an interview with one of our experts, please contact the media contact listed at the bottom of the news release.

  1. News Release

  2. May 14, 2025
JAMA Cardiology Letter Highlights Limitations and Risks of Semaglutide

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide highlighted in a letter published in the Journal of the American Medical Association (JAMA) Cardiology. The letter is published in response to research that found that more than half of U.S. adults, 137 million, are eligible for semaglutide for weight loss.